Pulse Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulse Biosciences, Inc. (PLSE) on May 20, 2024. The report addresses "Other Events" under Item 8.01, specifically regarding an update to the timing of a Rights Offering.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses solely on the announcement of a capital raise event.
Material Changes and Events
- Updated Rights Offering: The Company announced updated timing for a Rights Offering intended to raise up to $60,000,000.
- Reference Material: Detailed terms and the specific updated timeline are contained in the press release attached as Exhibit 99.1, which is not included in the provided text.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, operational outlook, or specific risk factors beyond the context of the capital raise. The primary purpose is to disclose the timing update for the offering.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific new dates and terms of the $60 million Rights Offering.
- Verify the subscription period and exercise price details for the rights offering.
- Check subsequent filings for the final outcome of the offering (e.g., total capital raised).